HIGHLIGHTS
- who: from the MicroRNAs as therapeutic targets in cardiovascular disease Bernhard Laggerbauer, and Stefan Engelhardt1, Institute of Pharmacology and Toxicology, Technical University of Munich (TUM), Munich, Germany DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance have published the paper: Characteristics and features of microRNAs, in the Journal: (JOURNAL)
- what: The authors report recent advances in the identification and characterization of microRNAs, their manipulation and clinical translation, and discuss challenges and perspectives toward clinical application.
SUMMARY
The Journal of Clinical Investigation MicroRNAs as therapeutic targets in cardiovascular disease Bernhard . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.